Yahoo! Finance: Biotechnology Industry News: Santarus and Pharming Announce Poster Presentation of Pivotal Clinical Data for RUCONEST (Recombinant Human C1 Esterase Inhibitor)

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Santarus and Pharming Announce Poster Presentation of Pivotal Clinical Data for RUCONEST (Recombinant Human C1 Esterase Inhibitor) Jun 25th 2013, 05:00 [Business Wire] - Santarus, Inc. and Pharming Group NV announced that new data from a pivotal Phase III clinical study with RUCONEST® for the treatment of acute angioedema attacks in patients with hereditary angioedema were featured in a poster presentation yesterday at the European Academy of Allergy and Clinical Immunology & World Allergy Organization World Allergy & Asthma Congress in Milan, Italy.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions